1. Professor Norbert H. Rietbrock

   • Uwe Fuhr
   • Sebastian Harder
   • Verbund Klinische Pharmakologie in Deutschland

   Obituary 20 September 2003 Pages: 497 - 498

2. A dose–response study of nitric oxide synthase inhibition in different vascular beds in man

   • Lisbeth Hjorth Lassen
   • Helle Klingenberg Iversen
   • Jes Olesen

   Pharmacodynamics 06 September 2003 Pages: 499 - 505

   

3. Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils

   • Shuren Li
   • Robert Dudczak
   • Peter Valent

   Pharmacodynamics 10 September 2003 Pages: 507 - 516

   

4. Genotype and allele frequency of CYP2D6 in Tamilian population

   • C. Adithan
   • N. Gerard
   • R. Krishnamoorthy

   Pharmacogenetics 27 August 2003 Pages: 517 - 520

   

5. Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing

   • Anna-Lena Zackrisson
   • Bertil Lindblom

   Pharmacogenetics 06 September 2003 Pages: 521 - 526

   

6. Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma

   • Kivanc Güngör
   • Mehtap Özkur
   • A. Sükrü Aynacioglu

   Pharmacogenetics 12 September 2003 Pages: 527 - 531

7. Xanthine oxidase activity is influenced by environmental factors in Ethiopians

   • Eleni Aklillu
   • Juan Antonio Carrillo
   • Magnus Ingelman-Sundberg

   Pharmacokinetics and Disposition 21 August 2003 Pages: 533 - 536

   

8. Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects

   • Michael Wolzt
   • Maria Wollbratt
   • Ulf G. Eriksson

   Pharmokinetics and Disposition 04 September 2003 Pages: 537 - 543

   

9. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

   • R. McGready
   • K. Stepniewska
   • F. Nosten

   Pharmacokinetics and Disposition 30 August 2003 Pages: 545 - 552

   

10. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil

    • R. McGready
    • K. Stepniewska
    • F. Nosten

    Pharmacokinetics and Disposition 30 August 2003 Pages: 553 - 557

    

11. Influence of material deprivation on prescribing patterns within a deprived population

    • D. Williams
    • C. Teljeur
    • J. Feely

    Pharmacoepidemiology and Prescription 27 August 2003 Pages: 559 - 563

    

12. Inappropriate use of anti-asthmatic drugs in the Italian paediatric population

    • Antonio Clavenna
    • Elisa Rossi
    • and the ARNO Working Group

    Pharmacoepidemiology and Prescription 06 September 2003 Pages: 565 - 569